Medmira Inc (TSE:MIR) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Medmira Inc. has strengthened its commercial team with the appointment of Rene Bell as the new Vice President of Business Development, bringing over 20 years of experience to the role. Bell is expected to boost direct sales and forge new partnerships, particularly in the US healthcare market, aligning with Medmira’s aggressive expansion strategy for its Rapid Vertical Flow diagnostics, including its G4 HIV and Miriad product lines. This move is part of the company’s broader 2024 strategy to enhance its market presence and revenue growth in the United States and beyond.
For further insights into TSE:MIR stock, check out TipRanks’ Stock Analysis page.